ReviewPharmacognosy reviews2013
Rasayans and non-rasayans herbs: Future immunodrug - Targets.
Review in Pharmacognosy reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Alternative and Complementary Therapies: A Review Exploring the Role of Yoga and Ayurveda-based Herbal Medicines in Alleviating Hypothyroidism and Its Neuropsychiatric Manifestations.Annals of neurosciences · 2026Review
- Deciphering the iridoids' boundaries: from soil ecology to anti-inflammatory medicines.Inflammopharmacology · 2025Review
- Phytochemical analysis ofWorld journal of experimental medicine · 2024Review
- Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19.Environmental science and pollution research international · 2021Review
- Effects ofCurrent neuropharmacology · 2021Review
- Evaluation of biological potential of selected species of family Poaceae from Bahawalpur, Pakistan.BMC complementary and alternative medicine · 2018Article
- Misleading "non-rasayanas".Pharmacognosy reviewsArticle
- An Ayurvedic personalized prophylactic protocol in COVID-19.Journal of Ayurveda and integrative medicineReview
- Ayurvedic management of neurological deficits post COVID-19 vaccination - A report of two cases.Journal of Ayurveda and integrative medicineArticle
- Humoral immune and adjuvant responses of mucosally-administered Tinospora cordifolia immunomodulatory protein in BALB/c mice.Journal of Ayurveda and integrative medicineArticle
- Reflections about Osteoarthritis andPharmacognosy reviewsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ayurvedic therapeutics describes vast number of medicinal herbs used as "Vyadhirodhak Chamatav" that has enlightened the application of herbs used as corner stone in various diseases especially those modulating the immune system. Ayurveda literature comprises of rasayana and non-rasayana herbs. Materia Medica entirely enriched with enormous data of rasayana medicinal herbs acting as immunomodulators in existence. However, as such there is no specific review of literature available for non-Rasayana herbs that have immense potential as immunomodulators. This review article empowers data on non-rasayana medicinal herbs as promising future target for immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.